COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION

Aim. To study efficiency and safety of new drug of long acting metoprolol tartrate, “Egilok retard” (ER) in patients with mild to moderate arterial hypertension (AH) in comparison with the original drug of metoprolol succinat, “Betaloc ZOK” (BZ), possibility of reaching target blood pressure (BP) le...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: J. V. Lukina, A. D. Deev, N. A. Dmitrieva, N. Y. Ivanenkova, A. A. Serazhim, G. F. Andreeva, S. Y. Martsevich
Format: Artigo
Sprog:Inglês
Udgivet: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Serier:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Fag:
metoprolol tartrate
metoprolol succinate
arterial hypertension
antihypertensive therapy
Online adgang:https://www.rpcardio.com/jour/article/view/367
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker